Skip to main content
Skip to main navigation
Search
The University of British Columbia
UBC - A Place of Mind
The University of British Columbia
campus
UBC Search
UBC Search
UBC COVID-19 Research
Main menu
Home
Research Projects
All Research Projects
Medical Response
Social and Policy Response
COVID-19 Researchers
COVID-19 Researchers
Funding & Resources
Funding Opportunities
Initiatives & Websites
Ethics and Approvals for COVID-19 Research
Access to High-Performance Computing and Storage
Facilities
Publications
News
News
UBC Researchers in the News
For Media
For Media
Donate
You are here
Home
|
People
|
Josef Penninger
Josef Penninger
Canada 150 Chair in Functional Genetics, Professor
Department of Medical Genetics
Faculty of Medicine
COVID-19 Research Area(s)
Vaccines & Treatments
COVID-19 Projects (UBC Lead)
Evaluating a potential drug therapy for COVID-19
i-GlyCO: Immunoglobulin Glycosylation during COVID-19
Molecular and cellular therapies against COVID-19 using angiotensin-converting enzyme 2 (ACE2)
SARS‐CoV‐2 Study for Eased Restrictions in British Columbia – SAfER
COVID-19 Publications and Articles
Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2
Related News, Media and Articles
COVID-19: UBC researcher leads team that found potential Achilles heel
Here are five projects by companies tackling COVID-19 to watch in Canada
UBC professor uses knowledge of SARS to develop COVID-19 drug
We are finally unravelling the mystery of what causes severe COVID-19
Is a bradykinin storm brewing in COVID-19?
Three ways to make coronavirus drugs in a hurry
Mini-organs push along COVID-19 and other virus research
Lab-grown mini human organs may play key role in coronavirus drug development: Scientists
Injection of 'decoy proteins' could stop the coronavirus infecting cells within the body, scientists say
World leading geneticist and immunologist Josef Penninger on potential COVID-19 treatment